INTERNATIONAL FINANCE SERVICES (Public limited company)
INTERNATIONAL FINANCE SERVICES is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0440.869.156. It was founded on 03-07-1990. Its registered office is in Woluwe-Saint-Pierre. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 25 974 352 and a profit of € 378 615. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 07-10-2026.
Company information
Key figures of INTERNATIONAL FINANCE SERVICES
| 2025 | 2024 | 2023 | |
|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 378 615+134 % | € 162 017-4 % | € 168 364 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 25 974 352-1 % | € 26 350 737-1 % | € 26 682 720 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 26 025 000-1 % | € 26 359 206-1 % | € 26 717 279 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 99 522-39 % | € 164 494+77 % | € 93 002 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Woluwe-Saint-Pierre.
| Company | Town |
|---|---|
| The Clem Corporation | 1150 Woluwe-Saint-Pierre |
| Transsignaal | 1150 Woluwe-Saint-Pierre |
| UNIVERFIMA | 1150 Woluwe-Saint-Pierre |
| H.G. CONSULTANT | 1150 Woluwe-Saint-Pierre |
| SAVEUR ET DELICATESSE | 1150 Woluwe-Saint-Pierre |
| IUS SOLI | 1150 Woluwe-Saint-Pierre |
| ANALYSE-RECHERCHE-DEVELOPPEMENT POUR L'INFORMATIQUE ET L'ENVIRONNEMENT | 1150 Woluwe-Saint-Pierre |
| FISHER PHARMACEUTICALS | 1150 Woluwe-Saint-Pierre |
Frequently asked questions
Is INTERNATIONAL FINANCE SERVICES still active? Yes. The Crossroads Bank for Enterprises lists INTERNATIONAL FINANCE SERVICES as active.
What is the VAT number of INTERNATIONAL FINANCE SERVICES? INTERNATIONAL FINANCE SERVICES is not registered for VAT. Its enterprise number is 0440.869.156.
When was INTERNATIONAL FINANCE SERVICES founded? INTERNATIONAL FINANCE SERVICES was founded on 03-07-1990.
What is the address of INTERNATIONAL FINANCE SERVICES? The current registered office of INTERNATIONAL FINANCE SERVICES is Avenue Marquis de Villalobar 90, 1150 Woluwe-Saint-Pierre.
When did INTERNATIONAL FINANCE SERVICES last file annual accounts? The latest annual accounts of INTERNATIONAL FINANCE SERVICES were filed on 22-05-2026.
Does INTERNATIONAL FINANCE SERVICES file its annual accounts on time? Yes. INTERNATIONAL FINANCE SERVICES filed its annual accounts within the legal deadline for each of its last 4 financial years.
Is INTERNATIONAL FINANCE SERVICES financially healthy? Addrly gives INTERNATIONAL FINANCE SERVICES a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is INTERNATIONAL FINANCE SERVICES profitable? The annual accounts of INTERNATIONAL FINANCE SERVICES for 2025 show a profit of € 378 615.
What is the equity of INTERNATIONAL FINANCE SERVICES? The equity of INTERNATIONAL FINANCE SERVICES was € 25 974 352 at the close of the 2025 financial year.
Who are the directors of INTERNATIONAL FINANCE SERVICES? The annual accounts of INTERNATIONAL FINANCE SERVICES record 5 mandates. The names, roles and dates are visible with a free account.
Can INTERNATIONAL FINANCE SERVICES receive Peppol e-invoices? Yes. INTERNATIONAL FINANCE SERVICES is registered on the Peppol network and can receive structured electronic invoices.
What does INTERNATIONAL FINANCE SERVICES do? The main activity of INTERNATIONAL FINANCE SERVICES is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.